The first multimodality coronary imaging catheter has recently received 510(k) clearance from the FDA. The LipiScan IVUS Coronary Imaging System (InfraReDx) device is the result of 10 years of ...

SAN DIEGO, Oct. 4, 2012 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC) a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of ...

The addition of IVUS to a fixed-dose catheter thrombolysis regimen failed to facilitate thrombus resolution in patients with acute iliofemoral deep vein thrombosis in the BERNUTIFUL trial. The ...

Results from the Lipid-Rich Plaque (LRP) study demonstrate the correlation between the presence of non-flow-limiting, non-intervened upon, lipid-rich plaques detected by NIRS-IVUS imaging and the ...

InfraReDx, Inc., a medical device company providing intelligent cardiovascular diagnostic imaging technologies, today announced it has received CE Mark approval to begin commercialization of the ...

September 2, 2010 — The US Food and Drug Administration has granted 510(k) clearance for a next-generation catheter-based coronary imaging system (LipiScan IVUS; InfraReDx Inc) to help clinicians ...

The Eagle Eye Platinum digital IVUS catheter is the #1 choice of physicians for intravascular imaging (in the US). As a unique plug-and-play intravascular imaging catheter it is designed for ease of ...

Biomedical engineers have combined intravascular ultrasound with fluorescence lifetime imaging in a single catheter probe that can image the tiny arteries of a living heart. The new catheter can ...

BURLINGTON, Mass.--(BUSINESS WIRE)--Infraredx, Inc., a pioneer in intravascular imaging for mapping coronary artery disease, today announced the Makoto™ Intravascular Imaging System, and accompanying ...

Volcano Corp. has announced it has received FDA clearance for its new intravascular ultrasound catheter, according to a news release. The Visions PV .035 digital IVUS catheter is designed to image ...